<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Agius JE</submitter><funding>Australia and Pacific Science Foundation</funding><funding>Holsworth Wildlife Research Endowment</funding><pagination>100116</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7386737</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>The pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin were determined following oral administration in 21 Asian house geckos (&lt;i>Hemidactylus frenatus&lt;/i>) at a dose of 10 mg/kg. Changes in enrofloxacin and ciprofloxacin plasma concentrations were quantified at regular intervals over 72 h (1, 2, 6, 12, 24, 48, and 72 h). Samples were analysed by high-pressure liquid chromatography (HPLC) and the enrofloxacin pharmacokinetic data underwent a two-compartment analysis. Due to the limited ciprofloxacin plasma concentrations above the lower limit of quantification (LLOQ), the ciprofloxacin data underwent non-compartment analysis and the half-life was determined by the Lineweaver-Burke plot and analysis. The enrofloxacin and ciprofloxacin mean half-lives (&lt;i>t&lt;/i> &lt;sub>½&lt;/</pubmed_abstract><journal>Veterinary and animal science</journal><pubmed_title>Pharmacokinetic profile of enrofloxacin and its metabolite ciprofloxacin in Asian house geckos (&lt;i>Hemidactylus frenatus&lt;/i>) after single-dose oral administration of enrofloxacin.</pubmed_title><pmcid>PMC7386737</pmcid><funding_grant_id>G200647</funding_grant_id><funding_grant_id>APSF 17/6</funding_grant_id><pubmed_authors>Kimble B</pubmed_authors><pubmed_authors>Govendir M</pubmed_authors><pubmed_authors>Rose K</pubmed_authors><pubmed_authors>Phalen DN</pubmed_authors><pubmed_authors>Agius JE</pubmed_authors><pubmed_authors>Pollard CL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pharmacokinetic profile of enrofloxacin and its metabolite ciprofloxacin in Asian house geckos (&lt;i>Hemidactylus frenatus&lt;/i>) after single-dose oral administration of enrofloxacin.</name><description>The pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin were determined following oral administration in 21 Asian house geckos (&lt;i>Hemidactylus frenatus&lt;/i>) at a dose of 10 mg/kg. Changes in enrofloxacin and ciprofloxacin plasma concentrations were quantified at regular intervals over 72 h (1, 2, 6, 12, 24, 48, and 72 h). Samples were analysed by high-pressure liquid chromatography (HPLC) and the enrofloxacin pharmacokinetic data underwent a two-compartment analysis. Due to the limited ciprofloxacin plasma concentrations above the lower limit of quantification (LLOQ), the ciprofloxacin data underwent non-compartment analysis and the half-life was determined by the Lineweaver-Burke plot and analysis. The enrofloxacin and ciprofloxacin mean half-lives (&lt;i>t&lt;/i> &lt;sub>½&lt;/</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-19T23:03:16.297Z</modification><creation>2025-04-19T23:03:16.297Z</creation></dates><accession>S-EPMC7386737</accession><cross_references><pubmed>32734117</pubmed><doi>10.1016/j.vas.2020.100116</doi></cross_references></HashMap>